Short Interest in Select Medical Holdings Corporation (NYSE:SEM) Drops By 14.0%

Select Medical Holdings Corporation (NYSE:SEM) saw a large decrease in short interest in the month of February. As of February 13th, there was short interest totaling 3,515,119 shares, a decrease of 14.0% from the January 29th total of 4,089,664 shares. Based on an average trading volume of 844,959 shares, the short-interest ratio is currently 4.2 days. Currently, 3.2% of the shares of the stock are short sold. Currently, 3.2% of the shares of the stock are short sold. Based on an average trading volume of 844,959 shares, the short-interest ratio is currently 4.2 days.

Analyst Ratings Changes

Several brokerages have commented on SEM. Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday. Benchmark reiterated a “hold” rating on shares of Select Medical in a research note on Wednesday. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, February 20th. Zacks Research cut Select Medical from a “hold” rating to a “strong sell” rating in a research report on Thursday, February 26th. Finally, Wall Street Zen raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Sunday, March 1st. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Select Medical has a consensus rating of “Hold” and a consensus price target of $15.63.

Select Medical Stock Performance

NYSE:SEM opened at $16.24 on Friday. The stock’s 50-day moving average is $15.37 and its 200-day moving average is $14.26. Select Medical has a 1-year low of $11.65 and a 1-year high of $18.60. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.89. The stock has a market cap of $2.01 billion, a P/E ratio of 14.12, a price-to-earnings-growth ratio of 0.92 and a beta of 1.22.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The business had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter last year, the business earned $0.18 EPS. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts anticipate that Select Medical will post 1.17 earnings per share for the current year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 12th. Investors of record on Monday, March 2nd will be paid a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s payout ratio is currently 21.74%.

Select Medical announced that its board has authorized a share buyback plan on Thursday, February 19th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the health services provider to repurchase up to 49.5% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.

Key Select Medical News

Here are the key news stories impacting Select Medical this week:

• Positive Sentiment: The March 4 trading reaction — shares jumped ~8.4% as traders bought ahead of expected delisting, signaling short‑term demand and liquidity around the deal. Select Medical (SEM) Soars 8.4%, Traders Snap up Shares Ahead of Delisting
• Positive Sentiment: Zacks notes the $16.50 take‑private price may be undervalued relative to some analyst targets, implying potential upside for shareholders who think bids or outcomes could improve. SEM’s $16.50 Take-Private Moment: Undervalued or Perfectly Timed?
• Neutral Sentiment: Royal Bank of Canada gave SEM a Sector Perform rating — a reiteration that suggests no near‑term conviction for outsized moves from the street. Select Medical (NYSE:SEM) Earns Sector Perform Rating from Royal Bank Of Canada
• Neutral Sentiment: Benchmark reaffirmed a “hold” on SEM, reflecting cautious analyst posture amid the pending transaction and mixed fundamentals. Benchmark Reaffirms Hold
• Neutral Sentiment: Recent quarterly results showed a modest EPS miss (Feb 19) but revenue beat and FY‑2026 guidance of $1.22–1.32 — investors should weigh fundamentals vs. takeover dynamics when valuing the $16.50 offer. Select Medical Stock & Earnings Summary
• Negative Sentiment: Kahn Swick & Foti announced an investigation into whether the sale price and process are adequate; such suits can delay closing, increase deal costs, or lead to renegotiation. Select Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process
• Negative Sentiment: Kaskela Law launched a separate probe into whether $16.50 is fair, increasing the chance of litigation or shareholder pushback that could affect timing and final consideration. SELECT MEDICAL STOCK ALERT: Kaskela Law Announces Investigation

Institutional Investors Weigh In On Select Medical

Institutional investors and hedge funds have recently made changes to their positions in the stock. Quarry LP bought a new position in shares of Select Medical during the fourth quarter worth about $26,000. Caitong International Asset Management Co. Ltd acquired a new stake in Select Medical during the 4th quarter valued at approximately $28,000. Quantbot Technologies LP bought a new position in Select Medical during the 3rd quarter worth approximately $27,000. MAI Capital Management lifted its position in shares of Select Medical by 48,000.0% in the 2nd quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,400 shares during the period. Finally, Hantz Financial Services Inc. boosted its stake in shares of Select Medical by 214.7% in the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 1,739 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.